MXCT vs WTW · rev $38.6M vs P/E 15, rev $9.93B
MaxCyte Inc (MXCT) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported WTW revenue for 2024-12-31 was $9.93B. Net income was -$88.0M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
MXCT currently screens at market cap $124.3M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the MXCT and WTW stock pages for the full models.
Not investment advice.